INS and Hypoglycemia: In a 24-week randomised controlled trial (RCT) comparing initiation of basal insulin added to OADs vs. twice-daily premixed insulin, the majority of patients in both groups (61.6% vs. 67.2%) experienced at least one episode of hypoglycaemia, but the prevalence was significantly higher in the premixed insulin group (4).